What is the official website of Friendly Care ?

The official website of Friendly Care is http://friendlycareinc.com.

What is Friendly Care's cybersecurity risk score?

Friendly Care has an AI-generated cybersecurity risk score of 651 out of 1000, indicating a Weak security posture according to Rankiteo's assessment.

How many security incidents has Friendly Care experienced?

According to Rankiteo, Friendly Care currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Friendly Care been affected by any supply chain cyber incidents ?

According to Rankiteo, Friendly Care has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Friendly Care have SOC 2 Type 1 certification ?

According to Rankiteo, Friendly Care is not certified under SOC 2 Type 1.

Does Friendly Care have SOC 2 Type 2 certification ?

According to Rankiteo, Friendly Care does not hold a SOC 2 Type 2 certification.

Does Friendly Care comply with GDPR ?

According to Rankiteo, Friendly Care is not listed as GDPR compliant.

Does Friendly Care have PCI DSS certification ?

According to Rankiteo, Friendly Care does not currently maintain PCI DSS compliance.

Does Friendly Care comply with HIPAA ?

According to Rankiteo, Friendly Care is not compliant with HIPAA regulations.

Does Friendly Care have ISO 27001 certification ?

According to Rankiteo,Friendly Care is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Friendly Care operate in ?

Friendly Care operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Friendly Care have ?

Friendly Care employs approximately 77 people worldwide.

Does Friendly Care own any subsidiaries ?

Friendly Care presently has no subsidiaries across any sectors.

How many LinkedIn followers does Friendly Care have ?

Friendly Care's official LinkedIn profile has approximately 39 followers.

What is the NAICS classification code for Friendly Care ?

Friendly Care is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Friendly Care have a Crunchbase profile ?

No, Friendly Care does not have a profile on Crunchbase.

Does Friendly Care have a LinkedIn profile ?

Yes, Friendly Care maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/friendly-care.

How many cybersecurity incidents has Friendly Care experienced ?

As of August 21, 2026, Rankiteo reports that Friendly Care has experienced 1 cybersecurity incidents.

How many peer or competitor companies does Friendly Care have ?

Friendly Care has an estimated 5,728 peer or competitor companies worldwide.

What types of cybersecurity incidents has Friendly Care faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Ransomware.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Friendly Care

Boost Score +25 with badge (5 left)

651

/1000

Weak

676

/1000

Weak

Friendly Care Vendor Cyber Rating & Cyber Score

friendlycareinc.com

Add Your Compliance Badge

Friendly Care A.I CyberSecurity Scoring

Scoring History

Friendly Care

Friendly Care CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Friendly Care

Ransomware

100

4/2026

FRI1776328117

Loading…

A.I.

Friendly Care Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Friendly Care

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Friendly Care has 34.64% fewer incidents than the average of same-industry companies with at least one recorded incident.

Incidents vs All-Companies Average (This Year)

Friendly Care has 2.91% fewer incidents than the average of all companies with at least one recorded incident.

Incident Types Friendly Care vs Pharmaceutical Manufacturing Industry Avg (This Year)

Friendly Care reported 1 incidents this year: 0 cyber attacks, 1 ransomware, 0 vulnerabilities, 0 data breaches, compared to industry peers with at least 1 incident.

Incident History - Friendly Care (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Friendly Care Subsidiaries

Parent Company

Friendly Care

Pharmaceutical Manufacturing

Website: http://friendlycareinc.com

Company Size: 11-50 employees

No subsidiary data available for this company.

Loading…

Friendly Care Similar Companies

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Parexel

parexel.com

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Intas Pharmaceuticals

intaspharma.com

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business. Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK. Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 23,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products. Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies. The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab. Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Loading…

NEWS

Friendly Care CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-77648

SUMMARY

In OpenStack Glance through 32.0.0, the /v2/tasks API accepts type=import tasks that bypass import_filtering_opts, allowing an admin to fetch internal URLs from the Glance service network (aka SSRF), as long as https:// or http:// is used. This API has been available only to admins since Xena, and it has been deprecated for several releases.

Published

Date2026-08-20

Updated

Date2026-08-20

RISK INFORMATION (Score: 2.2)

cvss3

Base Score: 2.2

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:H/UI:N/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

0.7

REFERENCES

CVE-2026-77647

SUMMARY

SPIP before 4.4.20 allows unauthenticated remote attackers to execute arbitrary code, as exploited in the wild in August 2026. This is related to incorrect identification of <?php blocks, and var_export's mishandling of certain cases such as presence of a '<' character.

Published

Date2026-08-20

Updated

Date2026-08-20

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

3.9

REFERENCES

CVE-2026-77113

SUMMARY

Path traversal in apport-unpack in Canonical Apport before 2.36.0, 2.34.2, and 2.28.4 on Linux allows an attacker to create or overwrite arbitrary files with the privileges of the executing user via an attacker controlled key names in crash report files.

Published

Date2026-08-20

Updated

Date2026-08-20

RISK INFORMATION (Score: )

cvss4

Base Score: 6.7

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:A/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-77646

SUMMARY

A Server-Side Request Forgery (SSRF) vulnerability has been reported in PTC Windchill PDMLink and PTC FlexPLM. The vulnerability may be exploited through the deserialization of untrusted data.

Published

Date2026-08-20

Updated

Date2026-08-20

RISK INFORMATION (Score: )

cvss4

Base Score: 7.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:Y/R:U/V:D/RE:M/U:Red

Impact Score

Exploitability

REFERENCES

https://www.ptc.com/en/support/article/CS474826

CVE-2026-77645

SUMMARY

A critical remote code execution (RCE) vulnerability has been reported in PTC Windchill and PTC FlexPLM. The vulnerability may be exploited through the deserialization of untrusted data.

Published

Date2026-08-20

Updated

Date2026-08-20

RISK INFORMATION (Score: )

cvss4

Base Score: 9.2

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:L/SI:L/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:Y/R:U/V:C/RE:M/U:Red

Impact Score

Exploitability

REFERENCES

https://www.ptc.com/en/support/article/CS474826

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…